Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.11.369
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Myeloablative Conditioning for Hematopoietic Stem-Cell Transplantation in Patients With Non-Malignant Diseases

Bone Marrow Transplantation
TransplantationHematology
2006English

Role of Conditioning Regimens in Pediatric Hematopoietic Stem Cell Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Outcomes From Unrelated Donor Hematopoietic Stem Cell Transplantation

Cancer Control
MedicineOncologyHematology
2011English

A Reduced-Intensity Conditioning Regimen for Patients With Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Unrelated Donor Hematopoietic Stem Cell Transplantation for the Treatment of Non-Malignant Genetic Diseases: An Alemtuzumab Based Regimen Is Associated With Cure of Clinical Disease; Earlier Clearance of Alemtuzumab May Be Associated With Graft Rejection

American Journal of Hematology
Hematology
2015English

HLA-Mismatch Is Associated With Worse Outcomes After Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation: A Cibmtr Analysis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Successful Treatment of Griscelli Syndrome With Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2002English

Allogeneic Hematopoietic Stem Cell Transplantation Using a Reduced Intensity Conditioning Regimen for Adolescents and Young Adults With Class 3 Beta-Thalassemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Non-Myeloablative Conditioning With Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia

Haematologica
Hematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy